Related Experiment Videos
Oxaliplatin-related side effects: characteristics and management
Jim Cassidy1, Jean-Louis Misset
1Department of Medicine and Therapeutics, University of Aberdeen, Institute of Medical Sciences, Aberdeen, Scotland.
Seminars in Oncology
|November 8, 2002
Summary
Oxaliplatin is an effective treatment for advanced colorectal cancer, offering scheduling flexibility. While it presents unique side effects like neurotoxicity, these are generally manageable and reversible, making it a safe therapeutic option.
Area of Science:
- Oncology
- Pharmacology
- Clinical Therapeutics
Background:
- Oxaliplatin is a third-generation platinum derivative used in cancer therapy.
- It is particularly effective for advanced colorectal cancer, often in combination with 5-fluorouracil/folinic acid (FOLFOX-4).
Purpose of the Study:
- To review the efficacy and safety profile of oxaliplatin in cancer treatment.
- To detail the unique side effect patterns of oxaliplatin compared to other platinum derivatives.
Main Methods:
- Clinical trial data analysis.
- Review of adverse event profiles, including hematologic, gastrointestinal, and neurologic toxicities.
- Assessment of nephrotoxicity and management strategies for side effects.
Main Results:
- Oxaliplatin demonstrates efficacy in advanced colorectal cancer with scheduling flexibility.
- Common side effects include hematologic toxicity (41.7% Grade 3/4 neutropenia) and neurotoxicity.
- Neurotoxicity is typically reversible within 13 weeks post-treatment.
- Gastrointestinal toxicity is generally mild and manageable, with 5-fluorouracil contributing more significantly.
- Nephrotoxicity has not been reported, allowing administration without hydration.
Conclusions:
- Oxaliplatin is a safe and effective treatment for colorectal cancer.
- Adverse events associated with oxaliplatin are manageable with appropriate patient and provider awareness.
- Its unique side effect profile, particularly neurotoxicity, requires specific management strategies.